Sgltr-M Tablet is a combination medication designed to help regulate blood sugar levels in adults with type 2 diabetes mellitus. It is used in conjunction with proper diet and exercise to enhance blood sugar control. This medication aids in the effective utilization of insulin, ultimately leading to a reduction in blood sugar levels. The tablet should be taken as directed by your healthcare provider, with or without food, at the same time each day to maintain consistency. It is important to adhere to the prescribed dose and schedule to optimize its effectiveness.

The primary components of Sgltr-M Tablet are Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate functions by eliminating excess sugar through urine, while Metformin hydrochloride reduces sugar production in the liver, delays sugar absorption in the intestines, and enhances the body's response to insulin. Together, these ingredients work synergistically to manage blood sugar levels effectively. It is essential to continue taking Sgltr-M Tablet as per your doctor's recommendations based on your specific medical condition.

While using Sgltr-M Tablet, some individuals may experience common side effects such as stomach upset, nausea, hypoglycemia, and vomiting. These side effects are usually temporary and tend to diminish over time. However, if they persist or worsen, it is advisable to consult your healthcare provider promptly. Inform your doctor if you have any existing kidney, liver, or heart issues before initiating treatment with Sgltr-M Tablet. Pregnant or breastfeeding women should also seek medical advice before starting this medication.

Your healthcare provider may monitor your blood sugar levels and kidney function regularly during Sgltr-M Tablet therapy to mitigate the risk of adverse effects. Lifestyle modifications such as maintaining a healthy diet, engaging in regular physical exercise, and refraining from excessive alcohol consumption may be recommended to enhance treatment outcomes. It is crucial to follow your doctor's guidance and report any unusual symptoms or concerns while using Sgltr-M Tablet to ensure the safe and effective management of diabetes.

Sgltr-M Tablet offers several benefits for individuals with Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels by helping eliminate excess glucose through urine. By effectively managing blood glucose levels, Reniva M reduces the risk of developing serious complications associated with diabetes, such as kidney damage, eye issues, nerve problems, and limb loss. Additionally, individuals with Type 2 diabetes who also have cardiovascular disease can benefit from this medication as it helps lower the risk of death from cardiovascular issues.

Regular use of Sgltr-M Tablet in conjunction with a proper diet and exercise regimen can significantly improve the quality of life for individuals with diabetes. It is important to adhere to the prescribed treatment plan as this medication is essential for protecting and maintaining future health. The combination of Remogliflozin and Metformin in Sgltr-M Tablet works synergistically to regulate blood sugar levels effectively. Remogliflozin assists in removing excess sugar through urine, while Metformin reduces sugar production in the liver, slows down sugar absorption from the intestines, and enhances the body's sensitivity to insulin. This combined action helps individuals better manage their diabetes and live a healthy, normal life.

To use Sgltr-M Tablet, follow the instructions provided by your doctor regarding the dosage and duration. It is recommended to take the tablet with food. Swallow the tablet whole with a glass of water, without crushing, chewing, or breaking it. You can take Sgltr-M Tablet either with food or after food, as advised by your doctor. Remember not to alter the tablet in any way before consuming it for the best results.

Sgltr-M Tablet is primarily used for the treatment of Type 2 diabetes mellitus. Type 2 diabetes is a condition where the body becomes resistant to insulin or does not produce enough insulin to maintain normal glucose levels. This medication helps manage blood sugar levels by combining two active ingredients, which are effective in controlling diabetes. It is important to follow the prescribed dosage and recommendations by healthcare professionals when using Sgltr-M Tablet to effectively manage Type 2 diabetes mellitus.

Sgltr-M Tablet is used to treat Type-2 diabetes mellitus. This condition is a chronic disease where the body cannot utilize insulin properly to control sugar levels in the blood. People with Type 2 diabetes may not produce enough insulin or have insulin resistance. Symptoms include lack of energy, frequent urination, blurry vision, and weight loss. This form of diabetes is commonly seen in middle-aged or older individuals and is also known as adult-onset diabetes.

If you experience any of the following symptoms while taking Sgltr-M Tablet, it is important to seek medical attention promptly.

1. Persistent urinary tract infection

2. Uncontrollable nausea or vomiting

3. Severe or persistent diarrhea

4. Intense abdominal pain

5. Significantly reduced appetite

6. Hypoglycemia (low blood sugar) symptoms such as dizziness, confusion, sweating, or shakiness

Additionally, if you have kidney, liver, or heart issues, or if you are pregnant or breastfeeding, consult your doctor before taking this medicine. It is crucial to keep your doctor informed about any concerning symptoms or changes in your health while using Reniva M to ensure safe and effective management of your diabetes.

When taking Sgltr-M Tablet, you may experience certain side effects. These effects are usually mild and temporary, getting better as your body gets used to the medication. However, if these side effects persist or cause concern, it is important to consult your doctor promptly. Common side effects may include urinary tract infections, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and hypoglycemia (low blood glucose level). You may also experience stomach upset and further instances of hypoglycemia, along with nausea and vomiting. It is essential to be aware of these potential side effects and seek medical advice if needed.

Before taking Sgltr-M Tablet, it is crucial to consider several factors for your safety and well-being. Firstly, if you have a known allergy to any of the components in the tablet, do not consume it. It is important to disclose to your doctor if you have existing heart issues, diabetic ketoacidosis, skin conditions, acute pancreatitis, low blood sugar levels, or kidney or liver problems before starting this medication. If you are pregnant or breastfeeding, consult your doctor prior to taking Sgltr-M Tablet. It is advisable to refrain from alcohol consumption while on this medication to avoid potential adverse reactions. Additionally, provide full information about all other medications you are currently taking and your overall health status to mitigate the risk of any unexpected side effects. Your doctor will guide you on the best course of action based on your individual circumstances.

When taking Sgltr-M Tablet, it is important to be aware of potential interactions with certain medical conditions. These include diabetic ketoacidosis, dialysis, skin disorders, acute pancreatitis, and hypoglycemia (low blood sugar levels). Patients with these conditions should exercise caution and consult with their healthcare provider before using Sgltr-M Tablet to ensure safety and effectiveness of the treatment. Proper management and monitoring are crucial to avoid any adverse effects or complications that may arise from these interactions.

If you forget to take a dose of Sgltr-M Tablet, try to take it as soon as you remember. But if it's close to the time for your next dose, just skip the missed dose and continue with your usual dosing schedule. Avoid taking a double dose to make up for the missed one.

For monitoring while using Sgltr-M Tablet, your healthcare provider may recommend a few related lab tests. These tests help in keeping track of your blood sugar levels and how well the medication is working for you. The tests include:

1. Glucose - Fasting Blood: This test measures the amount of sugar in your blood after fasting for a certain period. It helps to see your baseline blood sugar level.

2. Glucose - Postprandial Blood: This test checks your blood sugar levels after a meal, usually taken 2 hours after eating. It helps to evaluate how your body processes sugar after food intake.

3. Glycosylated Hemoglobin: Also known as HbA1c, this test shows your average blood sugar level over the past 2-3 months. It gives a broader picture of your blood sugar control.

These lab tests are essential to monitor your blood sugar levels and the effectiveness of Sgltr-M Tablet in managing your condition. Your healthcare provider will determine how often you need these tests based on your individual health needs and response to the medication.